Ingavirin

Ingavirin is the Russian military virologist, chief therapeutics Academician Alexander's team research and development, by one of the largest pharmaceutical companies in Russia Valenta company launched the market of new antiviral products, its influenza (H3N2 subtype, influenza A H1N1, H5N1), B virus, adenovirus has a high antiviral efficacy.

Its mechanism of action is to inhibit the viral nuclear replication stage, unlike the mechanism of action of current antiviral drugs, ingavirin inhibits the migration of the newly synthesized viral NP protein from the cytoplasm to the nucleus. This is an important stage when the virus infects the host.

Currently in Russia, CIS countries are also being used for COVID-19 treatment.

Product Name: Ingavirin

Synonyms: Pentanoic acid, 5-[[2-(1H-imidazol-4-yl)ethyl]amino]-5-oxo-;4-{[2-(1H-imidazol-5-yl)ethyl]carbamoyl}butanoic acid;Ingavirin;Pentanoic acid, 5-[[2-(1H-imidazol-5-yl)ethyl]amino]-5-oxo-;Ingavirin-D6

CAS: 219694-63-0

MF: C10H15N3O3

MW: 225.24